{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT00146432: Phase 2/Phase 3 Interventional Completed Septicemia
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03650348: Phase 1 Interventional Completed HER2-positive Breast Cancer
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03478488: Phase 3 Interventional Active, not recruiting Biliary Tract Neoplasms
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03698552: Phase 1/Phase 2 Interventional Recruiting Blasts 5 Percent or More of Bone Marrow Nucleated Cells
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03666273: Phase 1 Interventional Completed Advanced Solid Tumor
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04256148: Phase 2 Interventional Withdrawn Warm Autoimmune Hemolytic Anemia
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01946074: Phase 1 Interventional Completed Advanced Solid Tumors
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT04524455: Phase 1 Interventional Completed Acute Lymphoblastic Leukemia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02924402: Phase 1 Interventional Completed B-cell Non-Hodgkins Lymphoma
(2016)
Source URL:
Class:
PROTEIN
